NPS Pharmaceuticals (NPSP) has bought back the none-North American rights to two drugs from...

|About: NPS Pharmaceuticals, Inc. (NPSP)|By:, SA News Editor

NPS Pharmaceuticals (NPSP) has bought back the none-North American rights to two drugs from Takeda for $50M in shares and possible milestone payments, giving NPS with full global rights to the treatments. The drugs are Revestive (Gattex in the U.S.), a medicine for short bowel syndrome, and Preotact, a thyroid hormone replacement therapy. (PR)